| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 1.54e-07 | 3 | 108 | 3 | GO:0005220 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 2.34e-06 | 18 | 108 | 4 | GO:0015278 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 2.28e-05 | 31 | 108 | 4 | GO:0099604 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 2.93e-05 | 33 | 108 | 4 | GO:0005217 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 5.36e-05 | 14 | 108 | 3 | GO:0070679 | |
| GeneOntologyMolecularFunction | calcium channel activity | 7.22e-05 | 129 | 108 | 6 | GO:0005262 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.14e-04 | 140 | 108 | 6 | GO:0099094 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.72e-04 | 151 | 108 | 6 | GO:0015085 | |
| GeneOntologyMolecularFunction | gated channel activity | 4.65e-04 | 334 | 108 | 8 | GO:0022836 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 5.54e-04 | 343 | 108 | 8 | GO:0005261 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 6.38e-04 | 193 | 108 | 6 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 7.10e-04 | 197 | 108 | 6 | GO:0022834 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | GRIK4 NDUFA2 ATP13A2 ITPR1 ITPR2 TPCN1 ITPR3 CACNG6 HTR3D CACNA1G SLC4A4 | 9.39e-04 | 664 | 108 | 11 | GO:0008324 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | GRIK4 NDUFA2 ATP13A2 SLC4A3 ITPR1 ITPR2 TPCN1 ITPR3 CACNG6 HTR3D CACNA1G SLC4A4 | 1.20e-03 | 793 | 108 | 12 | GO:0015075 |
| GeneOntologyMolecularFunction | syntaxin binding | 1.28e-03 | 87 | 108 | 4 | GO:0019905 | |
| GeneOntologyMolecularFunction | protein transporter activity | 1.52e-03 | 42 | 108 | 3 | GO:0140318 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 1.61e-03 | 231 | 108 | 6 | GO:0005085 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 1.66e-03 | 316 | 108 | 7 | GO:0035091 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 1.13e-05 | 9 | 109 | 3 | GO:0031095 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 2.21e-05 | 11 | 109 | 3 | GO:0031094 | |
| GeneOntologyCellularComponent | RNA polymerase complex | 3.77e-05 | 119 | 109 | 6 | GO:0030880 | |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 6.55e-05 | 335 | 109 | 9 | GO:0061695 | |
| GeneOntologyCellularComponent | transcription factor TFIID complex | 1.05e-04 | 47 | 109 | 4 | GO:0005669 | |
| GeneOntologyCellularComponent | nuclear DNA-directed RNA polymerase complex | 3.15e-04 | 113 | 109 | 5 | GO:0055029 | |
| GeneOntologyCellularComponent | DNA-directed RNA polymerase complex | 3.56e-04 | 116 | 109 | 5 | GO:0000428 | |
| GeneOntologyCellularComponent | 90S preribosome | 4.57e-04 | 29 | 109 | 3 | GO:0030686 | |
| GeneOntologyCellularComponent | transferase complex | ERCC2 NEK10 POLA1 CUL9 ZNFX1 KEAP1 SOCS7 TAF6L FBXO6 TAF7L VHLL ASB4 WDR41 TAF4B | 4.81e-04 | 963 | 109 | 14 | GO:1990234 |
| GeneOntologyCellularComponent | intracellular protein-containing complex | ERCC2 POLA1 CUL9 ZNFX1 KEAP1 ITPR1 TAF6L FBXO6 CNOT9 TAF7L VHLL ASB4 WDR41 TAF4B | 5.27e-04 | 972 | 109 | 14 | GO:0140535 |
| GeneOntologyCellularComponent | RNA polymerase II, holoenzyme | 1.22e-03 | 89 | 109 | 4 | GO:0016591 | |
| HumanPheno | Cerebral calcification | 1.70e-05 | 151 | 40 | 8 | HP:0002514 | |
| HumanPheno | Intracranial calcification | 1.70e-05 | 151 | 40 | 8 | HP:0430048 | |
| HumanPheno | Abnormal temporal lobe morphology | 1.79e-05 | 152 | 40 | 8 | HP:0034221 | |
| Domain | InsP3_rcpt-bd | 1.73e-07 | 3 | 105 | 3 | IPR000493 | |
| Domain | MIR | 1.93e-07 | 10 | 105 | 4 | PF02815 | |
| Domain | MIR_motif | 1.93e-07 | 10 | 105 | 4 | IPR016093 | |
| Domain | MIR | 1.93e-07 | 10 | 105 | 4 | PS50919 | |
| Domain | MIR | 1.93e-07 | 10 | 105 | 4 | SM00472 | |
| Domain | ARM-type_fold | NEK10 SARM1 INTS1 MROH5 CUL9 ZNFX1 ITPR1 ITPR2 CNOT9 NOC4L KPNA3 | 3.26e-06 | 339 | 105 | 11 | IPR016024 |
| Domain | RIH_assoc-dom | 3.41e-06 | 6 | 105 | 3 | IPR013662 | |
| Domain | Ins145_P3_rec | 3.41e-06 | 6 | 105 | 3 | PF08709 | |
| Domain | RIH_assoc | 3.41e-06 | 6 | 105 | 3 | PF08454 | |
| Domain | RIH_dom | 3.41e-06 | 6 | 105 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 3.41e-06 | 6 | 105 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 3.41e-06 | 6 | 105 | 3 | IPR015925 | |
| Domain | - | 3.41e-06 | 6 | 105 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 3.41e-06 | 6 | 105 | 3 | PF01365 | |
| Domain | ARM-like | 1.43e-04 | 270 | 105 | 8 | IPR011989 | |
| Domain | Ion_trans_dom | 4.61e-04 | 114 | 105 | 5 | IPR005821 | |
| Domain | Ion_trans | 4.61e-04 | 114 | 105 | 5 | PF00520 | |
| Domain | - | 1.10e-03 | 9 | 105 | 2 | 3.40.1100.10 | |
| Domain | Band3_cytoplasmic_dom | 1.10e-03 | 9 | 105 | 2 | IPR013769 | |
| Domain | Band_3_cyto | 1.10e-03 | 9 | 105 | 2 | PF07565 | |
| Domain | PTrfase/Anion_transptr | 1.37e-03 | 10 | 105 | 2 | IPR016152 | |
| Domain | HCO3_transpt_euk | 1.37e-03 | 10 | 105 | 2 | IPR003020 | |
| Domain | HCO3_cotransp | 1.37e-03 | 10 | 105 | 2 | PF00955 | |
| Domain | HCO3_transpt_C | 1.37e-03 | 10 | 105 | 2 | IPR011531 | |
| Domain | - | 1.60e-03 | 222 | 105 | 6 | 1.25.10.10 | |
| Domain | MRGPCRFAMILY | 1.67e-03 | 11 | 105 | 2 | IPR026234 | |
| Domain | Myotubularin-like_Pase_dom | 2.73e-03 | 14 | 105 | 2 | IPR010569 | |
| Domain | PPASE_MYOTUBULARIN | 2.73e-03 | 14 | 105 | 2 | PS51339 | |
| Domain | Myotubularin_fam | 2.73e-03 | 14 | 105 | 2 | IPR030564 | |
| Domain | Myotub-related | 2.73e-03 | 14 | 105 | 2 | PF06602 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY | 2.25e-06 | 5 | 87 | 3 | M49000 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY | 4.48e-06 | 6 | 87 | 3 | M47960 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY | 1.86e-05 | 9 | 87 | 3 | M47852 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 2.64e-05 | 10 | 87 | 3 | M47661 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 3.61e-05 | 11 | 87 | 3 | M49033 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION | 3.61e-05 | 11 | 87 | 3 | M27466 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 4.26e-05 | 32 | 87 | 4 | MM14983 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 6.21e-05 | 13 | 87 | 3 | M47656 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 6.21e-05 | 13 | 87 | 3 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 6.21e-05 | 13 | 87 | 3 | M47751 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 6.21e-05 | 13 | 87 | 3 | MM14553 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 1.20e-04 | 16 | 87 | 3 | M26945 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 1.27e-04 | 42 | 87 | 4 | M791 | |
| Pathway | SIG_CHEMOTAXIS | 1.66e-04 | 45 | 87 | 4 | M5193 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION | 2.05e-04 | 19 | 87 | 3 | M27423 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.05e-04 | 19 | 87 | 3 | M47760 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY | 2.05e-04 | 19 | 87 | 3 | M47733 | |
| Pathway | KEGG_GAP_JUNCTION | 2.32e-04 | 90 | 87 | 5 | M4013 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 2.40e-04 | 20 | 87 | 3 | M47688 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 2.79e-04 | 21 | 87 | 3 | M47689 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.21e-04 | 22 | 87 | 3 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.21e-04 | 22 | 87 | 3 | M47675 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY | 3.63e-04 | 55 | 87 | 4 | M47952 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.68e-04 | 23 | 87 | 3 | M47676 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 4.73e-04 | 25 | 87 | 3 | MM14511 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 5.40e-04 | 61 | 87 | 4 | MM15071 | |
| Pathway | REACTOME_CA2_PATHWAY | 5.75e-04 | 62 | 87 | 4 | M27321 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 5.97e-04 | 27 | 87 | 3 | MM15053 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 5.97e-04 | 27 | 87 | 3 | M12123 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 6.65e-04 | 28 | 87 | 3 | M924 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 8.07e-04 | 178 | 87 | 6 | M2890 | |
| Pathway | KEGG_LONG_TERM_DEPRESSION | 9.10e-04 | 70 | 87 | 4 | M8232 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 9.10e-04 | 70 | 87 | 4 | M3115 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 1.01e-03 | 72 | 87 | 4 | MM14631 | |
| Pathway | KEGG_BASAL_TRANSCRIPTION_FACTORS | 1.29e-03 | 35 | 87 | 3 | M4864 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 1.36e-03 | 78 | 87 | 4 | M1921 | |
| Pathway | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | 1.40e-03 | 36 | 87 | 3 | M1315 | |
| Pathway | WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION | 1.40e-03 | 36 | 87 | 3 | M39831 | |
| Pathway | REACTOME_BICARBONATE_TRANSPORTERS | 1.64e-03 | 10 | 87 | 2 | M27335 | |
| Pathway | REACTOME_BICARBONATE_TRANSPORTERS | 1.64e-03 | 10 | 87 | 2 | MM15073 | |
| Pathway | REACTOME_RHOBTB3_ATPASE_CYCLE | 2.00e-03 | 11 | 87 | 2 | MM15681 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 2.04e-03 | 41 | 87 | 3 | M512 | |
| Pathway | REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING | 2.08e-03 | 146 | 87 | 5 | M27288 | |
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 10874040 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 9808793 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 20395455 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 17437169 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 18194433 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 18547250 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 36350267 | ||
| Pubmed | IP3 receptors regulate vascular smooth muscle contractility and hypertension. | 3.16e-08 | 3 | 111 | 3 | 27777977 | |
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 11413485 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 26009177 | ||
| Pubmed | Differential inositol 1,4,5-trisphosphate receptor signaling in a neuronal cell line. | 3.16e-08 | 3 | 111 | 3 | 17581770 | |
| Pubmed | Predominant role of type 1 IP3 receptor in aortic vascular muscle contraction. | 3.16e-08 | 3 | 111 | 3 | 18241669 | |
| Pubmed | Receptor-activated single channels in intact human platelets. | 3.16e-08 | 3 | 111 | 3 | 1693919 | |
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 19068129 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 23955339 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 31979185 | ||
| Pubmed | Tsg101 regulates PI(4,5)P2/Ca(2+) signaling for HIV-1 Gag assembly. | 3.16e-08 | 3 | 111 | 3 | 24904548 | |
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 17327232 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 16014380 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 17890015 | ||
| Pubmed | Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes. | 3.16e-08 | 3 | 111 | 3 | 23983250 | |
| Pubmed | Differential distribution of inositol trisphosphate receptor isoforms in mouse oocytes. | 3.16e-08 | 3 | 111 | 3 | 9858485 | |
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 20427533 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 25215520 | ||
| Pubmed | Inositol 1, 4, 5-trisphosphate receptor interacts with the SNARE domain of syntaxin 1B. | 1.26e-07 | 4 | 111 | 3 | 21424589 | |
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 28615414 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 10828023 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 28419336 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 11163362 | ||
| Pubmed | IP3R-mediated Ca2+ signaling controls B cell proliferation through metabolic reprogramming. | 1.26e-07 | 4 | 111 | 3 | 35494252 | |
| Pubmed | ERCC2 MTHFD2 ANXA3 CUL9 TOR4A KEAP1 RBM28 ITPR3 RIN1 MICAL2 LRCH4 PTCD3 KPNA3 | 1.27e-07 | 634 | 111 | 13 | 34591612 | |
| Pubmed | InsP₃receptors and Orai channels in pancreatic acinar cells: co-localization and its consequences. | 3.15e-07 | 5 | 111 | 3 | 21568942 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NDST1 ERCC2 INTS1 HECTD4 CUL9 TOR4A RHOT2 EDC4 ZNF865 ATP13A2 CDC42BPB ITPR2 TPCN1 ITPR3 ARHGEF40 SBF2 | 4.67e-07 | 1105 | 111 | 16 | 35748872 |
| Pubmed | ERCC2 MTHFD2 PEX1 CUL9 RHOT2 KEAP1 TAF6L VPS52 ARHGEF40 TAF7L SCRIB TAF4B LRRC41 ZNF574 PTCD3 KPNA3 | 5.32e-07 | 1116 | 111 | 16 | 31753913 | |
| Pubmed | 6.28e-07 | 6 | 111 | 3 | 23463619 | ||
| Pubmed | Sprouty2 regulates PI(4,5)P2/Ca2+ signaling and HIV-1 Gag release. | 6.28e-07 | 6 | 111 | 3 | 21762810 | |
| Pubmed | 6.28e-07 | 6 | 111 | 3 | 20519450 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 6.28e-07 | 6 | 111 | 3 | 25966694 | |
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 6.28e-07 | 6 | 111 | 3 | 16844763 | |
| Pubmed | 1.10e-06 | 7 | 111 | 3 | 11860456 | ||
| Pubmed | Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes. | 1.10e-06 | 7 | 111 | 3 | 22495310 | |
| Pubmed | 2.62e-06 | 9 | 111 | 3 | 25737585 | ||
| Pubmed | Type 1 and 3 inositol trisphosphate receptors are required for extra-embryonic vascular development. | 5.12e-06 | 11 | 111 | 3 | 27514653 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MTHFD2 SARM1 PEX1 RHOT2 NDUFA2 RBM28 ITPR1 ITPR2 ITPR3 VPS52 SNX6 COQ9 NOC4L WDR41 TMED10 MOV10 PTCD3 | 5.34e-06 | 1496 | 111 | 17 | 32877691 |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 6.67e-06 | 38 | 111 | 4 | 30786075 | |
| Pubmed | UTP6 POLA1 NOL6 INTS1 CUL9 RBM28 EDC4 ITPR3 NOC4L MOV10 PTCD3 | 8.15e-06 | 653 | 111 | 11 | 22586326 | |
| Pubmed | Isoform diversity of the inositol trisphosphate receptor in cell types of mouse origin. | 1.01e-05 | 2 | 111 | 2 | 9065779 | |
| Pubmed | Expression of IP3 receptor isoforms at the nodes of Ranvier in rat sciatic nerve. | 1.01e-05 | 2 | 111 | 2 | 17496801 | |
| Pubmed | Mutational analysis of the ligand binding site of the inositol 1,4,5-trisphosphate receptor. | 1.01e-05 | 2 | 111 | 2 | 8663526 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 15890645 | ||
| Pubmed | Mice lacking inositol 1,4,5-trisphosphate receptors exhibit dry eye. | 1.01e-05 | 2 | 111 | 2 | 24901844 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 33854148 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 18708078 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 15201137 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 19528657 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 8063813 | ||
| Pubmed | Cloning and characterization of human type 2 and type 3 inositol 1,4,5-trisphosphate receptors. | 1.01e-05 | 2 | 111 | 2 | 8081734 | |
| Pubmed | Sulphide signalling potentiates apoptosis through the up-regulation of IP3 receptor types 1 and 2. | 1.01e-05 | 2 | 111 | 2 | 23582047 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 1374893 | ||
| Pubmed | IP3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism. | 1.01e-05 | 2 | 111 | 2 | 16195467 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 15632133 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 20813840 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 15713744 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 7559486 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 20843799 | ||
| Pubmed | Type 1 and 2 IP3 receptors respond differently to catecholamines and stress. | 1.01e-05 | 2 | 111 | 2 | 19120126 | |
| Pubmed | Distinct roles of inositol 1,4,5-trisphosphate receptor types 1 and 3 in Ca2+ signaling. | 1.01e-05 | 2 | 111 | 2 | 14707143 | |
| Pubmed | 1.12e-05 | 14 | 111 | 3 | 34630045 | ||
| Pubmed | MTHFD2 NOL6 RHOT2 RBM28 EDC4 ITPR1 ITPR2 ITPR3 FBXO6 CNOT9 NOC4L SCRIB TMED10 MOV10 PTCD3 KPNA3 | 1.37e-05 | 1440 | 111 | 16 | 30833792 | |
| Pubmed | Synergistic Signaling by Light and Acetylcholine in Mouse Iris Sphincter Muscle. | 1.40e-05 | 15 | 111 | 3 | 28578927 | |
| Pubmed | NDST1 PDGFRB RBL2 PLA2G3 IQSEC2 HECTD4 CUL9 ZNFX1 CDC42BPB SLC4A3 LIMK1 SNX6 MICAL2 SCRIB KPNA3 | 1.48e-05 | 1285 | 111 | 15 | 35914814 | |
| Pubmed | Global genetic analysis in mice unveils central role for cilia in congenital heart disease. | 1.79e-05 | 100 | 111 | 5 | 25807483 | |
| Pubmed | HAUS6 MTHFD2 POLA1 RBL2 INTS1 KEAP1 EDC4 TAF6L VPS52 TINF2 NOC4L TMED10 LRRC41 ZNF574 KPNA3 | 2.15e-05 | 1327 | 111 | 15 | 32694731 | |
| Pubmed | Rescue of calcineurin Aα(-/-) mice reveals a novel role for the α isoform in the salivary gland. | 3.02e-05 | 3 | 111 | 2 | 21435446 | |
| Pubmed | Gene mapping within the T/t complex of the mouse. I. t-Lethal genes are nonallelic. | 3.02e-05 | 3 | 111 | 2 | 7074682 | |
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 22992961 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 22264824 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 12032348 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 32320395 | ||
| Pubmed | Sulforaphane is a Nrf2-independent inhibitor of mitochondrial fission. | 3.02e-05 | 3 | 111 | 2 | 27889639 | |
| Pubmed | Common variants on 14q32 and 13q12 are associated with DLBCL susceptibility. | 3.02e-05 | 3 | 111 | 2 | 21471979 | |
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 31421134 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 12421829 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 23223241 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 18250332 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 22033896 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 23000618 | ||
| Pubmed | 4.66e-05 | 22 | 111 | 3 | 11696558 | ||
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 25269472 | ||
| Pubmed | Abnormal taste perception in mice lacking the type 3 inositol 1,4,5-trisphosphate receptor. | 6.03e-05 | 4 | 111 | 2 | 17925404 | |
| Pubmed | Dopamine-Evoked Synaptic Regulation in the Nucleus Accumbens Requires Astrocyte Activity. | 6.03e-05 | 4 | 111 | 2 | 31954621 | |
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 21818117 | ||
| Pubmed | IRE1α/XBP1-mediated branch of the unfolded protein response regulates osteoclastogenesis. | 6.03e-05 | 4 | 111 | 2 | 26193638 | |
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 23884412 | ||
| Pubmed | Regulation of InsP3 receptor activity by neuronal Ca2+-binding proteins. | 6.03e-05 | 4 | 111 | 2 | 14685260 | |
| Pubmed | Ins(1,4,5)P3 receptor-mediated Ca2+ signaling and autophagy induction are interrelated. | 6.03e-05 | 4 | 111 | 2 | 22082873 | |
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 19120137 | ||
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 11524429 | ||
| Pubmed | 6.10e-05 | 24 | 111 | 3 | 10843712 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 8.73e-05 | 440 | 111 | 8 | 34244565 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 7.14e-08 | 3 | 76 | 3 | 297 | |
| GeneFamily | UPF1 like RNA helicases | 9.36e-04 | 11 | 76 | 2 | 1169 | |
| GeneFamily | Myotubularins|Phosphoinositide phosphatases | 1.77e-03 | 15 | 76 | 2 | 903 | |
| GeneFamily | Dyneins, axonemal | 2.28e-03 | 17 | 76 | 2 | 536 | |
| Drug | CAS 298-57-7 | 1.37e-06 | 73 | 109 | 6 | CID000002761 | |
| Drug | Calycanthine [595-05-1]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 4.73e-06 | 196 | 109 | 8 | 2764_DN | |
| Drug | 3-nitropropionic acid; Up 200; 10uM; MCF7; HT_HG-U133A | 4.91e-06 | 197 | 109 | 8 | 6367_UP | |
| Drug | isovalerate | 5.81e-06 | 143 | 109 | 7 | CID000010430 | |
| Drug | Cinildipine | 7.21e-06 | 56 | 109 | 5 | CID000002752 | |
| Drug | nilvadipine | 1.02e-05 | 60 | 109 | 5 | CID000004494 | |
| Drug | lercanidipine | 1.29e-05 | 63 | 109 | 5 | CID000065866 | |
| Drug | gallopamil | 1.75e-05 | 67 | 109 | 5 | CID000001234 | |
| Drug | Gsts | 2.01e-05 | 173 | 109 | 7 | CID000128079 | |
| Drug | AC1L2AC7 | 2.02e-05 | 69 | 109 | 5 | CID000068733 | |
| Drug | adenophostin A | 2.27e-05 | 2 | 109 | 2 | ctd:C085029 | |
| Drug | Isocaffeine | 2.27e-05 | 2 | 109 | 2 | CID000001326 | |
| Drug | adenophostin B | 2.27e-05 | 2 | 109 | 2 | CID000656722 | |
| Drug | benzene 1,2,4-trisphosphate | 2.27e-05 | 2 | 109 | 2 | CID000192376 | |
| Drug | ethosuximide | 2.84e-05 | 74 | 109 | 5 | CID000003291 | |
| Drug | pimozide | 3.39e-05 | 127 | 109 | 6 | CID000016362 | |
| Drug | nisoldipine | 3.67e-05 | 78 | 109 | 5 | CID000004499 | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; PC3; HT_HG-U133A | 3.79e-05 | 191 | 109 | 7 | 4289_DN | |
| Drug | Chlorzoxazone [95-25-0]; Down 200; 23.6uM; HL60; HG-U133A | 4.19e-05 | 194 | 109 | 7 | 1416_DN | |
| Drug | Xylometazoline hydrochloride [1218-35-5]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 4.47e-05 | 196 | 109 | 7 | 2270_UP | |
| Drug | Testosterone propionate [57-85-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 4.47e-05 | 196 | 109 | 7 | 5636_DN | |
| Drug | Sulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 4.62e-05 | 197 | 109 | 7 | 5507_DN | |
| Drug | Norethindrone [68-22-4]; Down 200; 13.4uM; PC3; HT_HG-U133A | 4.62e-05 | 197 | 109 | 7 | 5055_DN | |
| Drug | Suprofen [40828-46-4]; Down 200; 15.4uM; HL60; HT_HG-U133A | 4.62e-05 | 197 | 109 | 7 | 3005_DN | |
| Drug | 1zz2 | 4.67e-05 | 82 | 109 | 5 | CID005287728 | |
| Drug | ICI 182,780; Down 200; 0.01uM; PC3; HT_HG-U133A | 4.77e-05 | 198 | 109 | 7 | 1238_DN | |
| Drug | Zalcitabine [7481-89-2]; Down 200; 19uM; MCF7; HT_HG-U133A | 4.92e-05 | 199 | 109 | 7 | 4799_DN | |
| Drug | alpha-estradiol; Down 200; 0.01uM; PC3; HT_HG-U133A | 4.92e-05 | 199 | 109 | 7 | 1210_DN | |
| Drug | DAPH; Up 200; 10uM; PC3; HG-U133A | 4.92e-05 | 199 | 109 | 7 | 578_UP | |
| Drug | 5-deoxy-5-fluoro-myo-inositol | 6.79e-05 | 3 | 109 | 2 | CID000195110 | |
| Drug | fullerene C60 | LNX2 PDGFRB KEAP1 EDC4 ATP13A2 CDC42BPB TPCN1 ITPR3 TG TAF6L LIMK1 TINF2 RAPGEF3 DNAH17 PTCH2 CACNA1G TAF4B MUC6 ZNF574 | 8.47e-05 | 1498 | 109 | 19 | ctd:C069837 |
| Drug | manidipine | 9.43e-05 | 95 | 109 | 5 | CID000004008 | |
| Drug | nitrendipine | 1.09e-04 | 98 | 109 | 5 | CID000004507 | |
| Drug | isradipine | 1.20e-04 | 100 | 109 | 5 | CID000003784 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 1.05e-05 | 12 | 109 | 3 | DOID:1441 (implicated_via_orthology) | |
| Disease | Hypoxic Brain Damage | 1.35e-05 | 2 | 109 | 2 | C1140716 | |
| Disease | Anoxic Encephalopathy | 1.35e-05 | 2 | 109 | 2 | C0003132 | |
| Disease | Brain Hypoxia | 1.35e-05 | 2 | 109 | 2 | C1527348 | |
| Disease | Anoxia of brain | 1.35e-05 | 2 | 109 | 2 | C0995195 | |
| Disease | diastolic blood pressure, alcohol drinking | 7.88e-05 | 118 | 109 | 5 | EFO_0004329, EFO_0006336 | |
| Disease | protein wnt-7a measurement | 8.07e-05 | 4 | 109 | 2 | EFO_0020689 | |
| Disease | urinary potassium to creatinine ratio | 2.01e-04 | 6 | 109 | 2 | EFO_0009882 | |
| Disease | Chronic Obstructive Asthma | 2.01e-04 | 6 | 109 | 2 | EFO_0009759 | |
| Disease | mean arterial pressure, alcohol drinking | 4.87e-04 | 98 | 109 | 4 | EFO_0004329, EFO_0006340 | |
| Disease | WNT1-inducible-signaling pathway protein 1 measurement | 5.97e-04 | 10 | 109 | 2 | EFO_0008321 | |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 8.71e-04 | 12 | 109 | 2 | DOID:3827 (implicated_via_orthology) | |
| Disease | hypertension | 9.98e-04 | 307 | 109 | 6 | EFO_0000537 | |
| Disease | kallikrein-12 measurement | 1.03e-03 | 13 | 109 | 2 | EFO_0008194 | |
| Disease | obesity (implicated_via_orthology) | 1.24e-03 | 215 | 109 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | systolic blood pressure, alcohol drinking | 1.32e-03 | 128 | 109 | 4 | EFO_0004329, EFO_0006335 | |
| Disease | Williams-Beuren syndrome (implicated_via_orthology) | 1.38e-03 | 15 | 109 | 2 | DOID:1928 (implicated_via_orthology) | |
| Disease | Ischemic stroke, tissue plasminogen activator measurement | 1.38e-03 | 15 | 109 | 2 | EFO_0004791, HP_0002140 | |
| Disease | N-acetylmethionine measurement | 1.38e-03 | 15 | 109 | 2 | EFO_0021427 | |
| Disease | anemia (implicated_via_orthology) | 1.38e-03 | 15 | 109 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | Huntington's disease (biomarker_via_orthology) | 1.57e-03 | 16 | 109 | 2 | DOID:12858 (biomarker_via_orthology) | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 2.09e-03 | 145 | 109 | 4 | DOID:1289 (implicated_via_orthology) | |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 2.22e-03 | 19 | 109 | 2 | DOID:10003 (implicated_via_orthology) | |
| Disease | factor VIII measurement, Ischemic stroke | 2.22e-03 | 19 | 109 | 2 | EFO_0004630, HP_0002140 | |
| Disease | maximal midexpiratory flow rate | 2.46e-03 | 20 | 109 | 2 | EFO_0004313 | |
| Disease | Alzheimer's disease (is_marker_for) | 2.70e-03 | 257 | 109 | 5 | DOID:10652 (is_marker_for) | |
| Disease | Infiltrating duct carcinoma of female breast | 2.71e-03 | 21 | 109 | 2 | C3165106 | |
| Disease | hyperglycemia (biomarker_via_orthology) | 2.71e-03 | 21 | 109 | 2 | DOID:4195 (biomarker_via_orthology) | |
| Disease | Parkinson's disease (implicated_via_orthology) | 2.78e-03 | 157 | 109 | 4 | DOID:14330 (implicated_via_orthology) | |
| Disease | infant body height | 3.25e-03 | 23 | 109 | 2 | EFO_0006785 | |
| Disease | leptin measurement | 3.39e-03 | 81 | 109 | 3 | EFO_0005000 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PGQRRLDLFSCLLRH | 716 | Q76B58 | |
| LRHCLLPRLFQDREL | 1191 | P48751 | |
| PVFLQVHLRSARRLC | 76 | Q86TW2 | |
| LIKSSCRPQFQRRFH | 6 | Q6NVV9 | |
| FLRELQGCATHPLRI | 1141 | Q8TER5 | |
| AIRRTLHNRCHRAIP | 391 | Q9Y574 | |
| CVRNTPAFLAERLHR | 246 | P12429 | |
| HVVRCYLRLSDNPRA | 231 | Q92600 | |
| ELYLRPLRRHIQCLQ | 336 | Q96DT5 | |
| LLILSLFRRLHCTRN | 156 | P48546 | |
| NTLVCAAVIRFRHLR | 41 | P21728 | |
| VFRHSVRALLQRVSP | 191 | Q9BXT2 | |
| THVPARQLLLNCRLV | 26 | Q9NRD1 | |
| LPRHTCSGLQVRFLR | 411 | O00189 | |
| NIFVSRTRLCLHNLP | 481 | Q9NW13 | |
| VVSRCRLRHTEVLPA | 466 | Q6P2E9 | |
| VPRNSYVRLRHLCTN | 381 | Q14571 | |
| VPRNSYVRLRHLCTN | 381 | Q14573 | |
| RRACQLLLLHSLFPV | 6 | Q9UJ68 | |
| VSRIPVSFCRLRHLQ | 216 | O75427 | |
| RICPENHSALLRRLQ | 1116 | Q08999 | |
| LVLIAFCIIRRRPSA | 336 | P34810 | |
| PGRRLVLTLQVFSHC | 2416 | Q6W4X9 | |
| CLRRFHVFARSPALQ | 341 | Q96EY7 | |
| LFLRLLRSPHQNVCE | 161 | O00505 | |
| LFRLQPATLHCRLLR | 96 | Q9P2G4 | |
| RMTCRLLLHLFRAPQ | 1126 | Q86YW9 | |
| IRHNLSSNRCFRKVP | 81 | O75593 | |
| RLGHLLCRSRNPDFL | 861 | Q8N201 | |
| LCRSRNPDFLLHIIQ | 866 | Q8N201 | |
| LVPRNSYVRLRHLCT | 381 | Q14643 | |
| QLAHLRLRALCLPDS | 316 | A4FU01 | |
| SSLPRVARCYRHNRL | 1166 | Q86WG5 | |
| LLVNVLCAVLSHRRR | 151 | Q96N19 | |
| CRDFRLRAAHLPLLT | 581 | Q5JU85 | |
| PCNTLHLTVLRERRF | 306 | Q8N448 | |
| RRTVCLNLPVLTLQH | 16 | P86397 | |
| RAPSIHFLRVLICLR | 126 | Q6ZWH5 | |
| RALCHALTFPSLQRL | 156 | Q63ZY6 | |
| LRPLSRLQAACHRLK | 476 | Q9H6R4 | |
| CLRRLCRHVSPQAVL | 6 | P52848 | |
| QLRLPHTLRCANITI | 186 | Q9UBX7 | |
| PLRFCAERLRSLLHT | 371 | P18074 | |
| LRRFPLHVCSFRELV | 41 | Q5BKY1 | |
| RNVECLQPLTHLKRR | 376 | A2A3K4 | |
| HATRRDIPCIFRVTA | 1166 | Q9Y5S2 | |
| FCLRQFPRSLLERHQ | 141 | Q6ZMK1 | |
| INQLCRHLAITPARL | 3471 | Q9Y4D8 | |
| PTCRNRTRHLPLQFS | 1351 | P09884 | |
| THRLLFRCPRLLNLG | 281 | Q9NYR8 | |
| RAIPDTRHLRCTLLV | 91 | Q96FL9 | |
| VRLRLRQRQPHVCYE | 461 | Q8IYK2 | |
| SRLRRQGIFCIHPLR | 486 | Q9NQ11 | |
| RPRASHVLCHIRFPL | 241 | Q53HC5 | |
| PQSRFRLLCHRIITH | 1261 | O43497 | |
| AHICRINRILESPRG | 2781 | Q9UFH2 | |
| IARCHFARSRFLQIL | 166 | Q7Z4H7 | |
| ALLRAVRCHSLTPNF | 266 | Q14145 | |
| LLQLCPRLNRVLRHE | 1336 | Q8IWT3 | |
| ASFASRVRRLCHLLV | 1416 | Q8IWT3 | |
| ARCRQALVPRAFHAS | 26 | O75208 | |
| NICHLRRFRSVPRNL | 311 | Q16610 | |
| SIILCQDSIHPRRRR | 851 | Q16099 | |
| ICNLLRRHPACRVLV | 391 | Q9BVI4 | |
| FTNARDCFLHLPRRL | 21 | O43933 | |
| RSGLALCAIIHRFRP | 546 | O94851 | |
| LCAIIHRFRPELINF | 551 | O94851 | |
| RLQHVDRPLSVRCTL | 496 | P09619 | |
| ARLTRGLECPALQHR | 441 | Q7Z6I6 | |
| AIRLRLCSVHIPQAK | 781 | Q6ZUA9 | |
| LREIRIHLCQRSPGS | 16 | O43678 | |
| FRELLRCALVRARPA | 171 | Q92737 | |
| VHPIILLFSNCRLRA | 291 | P59551 | |
| QLHRPRITRICLRDL | 826 | Q92750 | |
| LLQVARSLFRNPHLC | 216 | Q9Y6J9 | |
| QFILRLPLEHACTVR | 101 | Q5H9L4 | |
| ARQLFLRALRFHPEC | 161 | Q9NYH9 | |
| RRLPATHCFQHLLRV | 616 | Q13671 | |
| HLCSRLINGPYRRTV | 161 | Q96MN5 | |
| LLETFRPQRCAQVLH | 331 | O60522 | |
| RSRIRFIHLVTGCVL | 471 | Q9UKY4 | |
| DRRLCDQRFSPLLHS | 146 | Q15345 | |
| LRPACAQALTRIFRL | 181 | Q8IXI1 | |
| DLLCQRLRVHLPSSI | 561 | Q9HCE1 | |
| PCLALILHVECRARR | 216 | Q96AM1 | |
| CSLRLRPFHLAAVRN | 21 | P13995 | |
| AAFHVFRIECPRRLS | 471 | Q8N6K7 | |
| FPAILSLDLRRRHCQ | 546 | Q9Y6C5 | |
| RELSRIIICNHSPRI | 51 | Q6RSH7 | |
| PLRQRHVACLARSER | 856 | Q14160 | |
| RCRRPTHLSAVVCVL | 131 | Q96LA9 | |
| RPAILHSLKFCRERV | 131 | Q5T5C0 | |
| NCTRRLARFLRLHSP | 396 | Q9NZ20 | |
| QAIFHVAIRRRCRPS | 216 | Q70Z44 | |
| CFVRSLLRVQLLPRT | 61 | G3V211 | |
| FLAHRVALAALPCRR | 6 | O60930 | |
| LRCIPVHAFNGLRSL | 811 | O75094 | |
| CIHIVLRFRNIAAKR | 446 | Q8N1B4 | |
| RHLLATCPNLIRDRK | 106 | O95398 | |
| LTRHRQVHRLQLPCA | 621 | P0CJ78 | |
| RRTDPALLRHCALAL | 216 | Q6SZW1 | |
| AISFHLPINSRKCLR | 31 | P49755 | |
| RCVEHFPRVLEFLRS | 26 | Q9BSI4 | |
| LSRADLVLLAHRPRC | 206 | Q8WZ04 | |
| ECPRSFLLRRLLEVH | 611 | Q6ZN55 | |
| LCRFRIRQLVRIDHI | 521 | O14512 | |
| VFLCRVAAHPILRRD | 146 | Q9UNH7 | |
| RFHERCQQPCKRLLI | 1456 | Q9P2E3 | |
| LICRRLCQFSTRVHP | 361 | Q9H8X9 | |
| SHVRVTRALRCIFLV | 196 | Q9ULQ1 | |
| KDRVLPHRRQVSLAC | 111 | Q71RG6 | |
| PRVEHRSRAQRCLLL | 111 | Q9NXH8 | |
| PLRRVHLFTFLQVLC | 946 | Q9Y6R1 | |
| RRQVLSGHLPFCRFR | 516 | Q9H8Y1 | |
| PRSCEIRNRRLLHGV | 161 | P01266 | |
| VLHVARLPNRQLISC | 326 | Q9HAD4 | |
| SESLRVVCRPHRIFR | 321 | P53667 |